US2012184020A1PendingUtilityA1
Engineered microorganisms with enhanced fermentation activity
Est. expiryJul 9, 2029(~3 yrs left)· nominal 20-yr term from priority
C12P 7/10C12N 9/92C12N 9/88Y02E50/10
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are genetically modified microorganisms that have enhanced fermentation activity, and methods for making and using such microorganisms.
Claims
exact text as granted — not AI-modified1 - 52 . (canceled)
53 . A eukaryotic cell comprising a polypeptide having xylose isomerase activity, which polypeptide comprises an amino acid sequence greater than that 65.8% identical to SEQ ID NO: 31.
54 . The eukaryotic cell of claim 53 , wherein the polypeptide comprises an amino acid sequence that is 75% or more identical to SEQ ID NO: 31.
55 . The eukaryotic cell of claim 54 , wherein the polypeptide comprises an amino acid sequence that is 80% or more identical to SEQ ID NO: 31.
56 . The eukaryotic cell of claim 55 , wherein the polypeptide comprises an amino acid sequence that is 85% or more identical to SEQ ID NO: 31.
57 . The eukaryotic cell of claim 56 , wherein the polypeptide comprises an amino acid sequence that is 90% or more identical to SEQ ID NO: 31.
58 . The eukaryotic cell of claim 57 , wherein the polypeptide comprises an amino acid sequence that is 95% or more identical to SEQ ID NO: 31.
59 . The eukaryotic cell of claim 58 , wherein the polypeptide comprises an amino acid sequence of SEQ ID NO: 31.
60 . The eukaryotic cell of claim 59 , wherein the polypeptide consists of an amino acid sequence of SEQ ID NO: 31.
61 . The eukaryotic cell of claim 53 , which is a yeast cell.
62 . The eukaryotic cell of claim 61 , which is a Saccharomyces spp. cell.
63 . The eukaryotic cell of claim 62 , which is a Saccharomyces cerevisiae cell.
64 . An engineered yeast comprising a chimeric enzyme having xylose isomerase activity, wherein:
the C-terminal region of the chimeric enzyme comprises at least 5 contiguous amino acids from a bacterial xylose isomerase enzyme; and the N-terminal region of the chimeric enzyme comprises at least 5 contiguous amino acids from a fungal xylose isomerase enzyme.
65 . The engineered yeast of claim 64 , wherein the bacterial xylose isomerase enzyme is a Ruminococcus spp. xylose isomerase enzyme.
66 . The engineered yeast of claim 65 , wherein the Ruminococcus spp. xylose isomerase enzyme is from a Ruminococcus flavefaciens strain.
67 . The engineered yeast of claim 66 , wherein the Ruminococcus flavefaciens strain is selected from the group consisting of Ruminococcus flavefaciens strain 17 , Ruminococcus flavefaciens strain Siijpesteijn 1948, and Ruminococcus flavefaciens strain FD1.
68 . The engineered yeast of claim 66 , wherein the at least 5 contiguous amino acids from the bacterial xylose isomerase enzyme are from SEQ ID NO: 31.
69 . The engineered yeast of claim 64 , wherein the fungal xylose isomerase enzyme is from a fungus selected from the group consisting of an Aspergillus spp. fungus, Thraustochytrium spp. fungus, Schizochytrium spp. fungus, Rhizopus spp. fungus, Orpinomyces spp. fungus and Piromyces spp. fungus.
70 . The engineered yeast of claim 69 , wherein the fungal xylose isomerase enzyme is from a Piromyces spp. fungus.
71 . The engineered yeast of claim 70 , wherein the Piromyces spp. fungus is a Piromyces strain E2 fungus.
72 . The engineered yeast of claim 71 , wherein the at least 5 contiguous amino acids from the fungal xylose isomerase enzyme are from SEQ ID NO: 35.
73 . The engineered yeast of claim 64 , which is an engineered Saccharomyces spp. yeast.
74 . The engineered yeast of claim 73 , which is an engineered Saccharomyces cerevisiae yeast.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.